San Diego, CA, United States of America

Sarah Rue

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Sarah Rue: Pioneering Innovations in Biomedical Research

Introduction: Inventor Sarah Rue, based in San Diego, CA (US), is a trailblazing woman with a remarkable portfolio of 5 patents in the field of biomedical research.

Latest Patents:

Sarah Rue's latest patents showcase her groundbreaking work in the development of novel therapies:

1. ENTPD2 Antibodies: Rue's invention includes antibodies that specifically target ENTPD2, providing new avenues for therapeutic applications.

2. Combination Therapies: She has also introduced combination therapies involving anti-human ENTPD2 antibodies and additional therapeutic agents for enhanced treatment outcomes.

3. Anti-CCR7 Antibody Drug Conjugates: Rue's patent on anti-CCR7 antibodies and drug conjugates demonstrates her commitment to advancing cancer treatment through innovative approaches.

Career Highlights:

Throughout her career, Sarah Rue has made significant contributions to the field of biomedical research. She has worked with esteemed companies such as Novartis AG and Elanco Tiergesundheit AG, where she has played a pivotal role in driving innovation and research forward.

Collaborations:

Rue has collaborated with accomplished professionals like Brendan P Eckelman and Quinn L Deveraux, fostering a collaborative environment where diverse expertise converges to push the boundaries of scientific discovery.

Conclusion:

Inventor Sarah Rue's indomitable spirit and unwavering commitment to pushing the boundaries of biomedical research have solidified her position as a leading innovator in the field. Her patents stand as a testament to her dedication to improving healthcare outcomes and revolutionizing the treatment landscape for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…